Latino

Novavax completes enrolling 30,000 people in U.S. trial of Covid-19 vaccine

African-Americans, Biomedical Advanced Research and Development Authority (BARDA), Clinical Trials, COVID-19 Vaccines, Latino, Mexico, Novavax, R&D, Reuters, Serum Institute of India, United Kingdom, United States

Drug developer Novavax Inc. completed enrolling 30,000 volunteers in a late-stage study of the company’s Covid-19 vaccine in the United States and Mexico.

February 22, 2021/by Andrew Humphreys

Poll: 47% of Americans Hesitant to Get Covid-19 Vaccine

21st Century Cures Act, African-Americans, Caucasians, COVID-19 Vaccinations, Latino, Los Angeles Times, NPR, Online, Polls, Surveys, U.S. Centers for Disease Control and Prevention, United States, Washington

Many Americans are hesitant to be vaccinated against Covid-19, according to research from Invisibly.

January 22, 2021/by Andrew Humphreys

Abbott Becomes First Anchor Sponsor of American Diabetes Association’s Health Equity Now Initiative

African-Americans, American Diabetes Association, Asians, Business, Coronavirus Disease (COVID-19) Pandemic, Diabetes, Health Disparities, Household Income, Initiatives, Latino

Abbott became the first anchor sponsor of the American Diabetes Association’s Health Equity Now platform to address health disparities for people with diabetes.

November 18, 2020/by PR Newswire

Moderna’s Covid-19 vaccine shows similar immune response in old and young

African-Americans, Agreements, American Indians, Analysis, Business, Clinical Trials, Coronavirus Disease (COVID-19) Pandemic, COVID-19 Vaccines, Immune Response, Immunizations, Interim Data, Latino, R&D, Shares, U.S. Centers for Disease Control and Prevention, U.S. government

Moderna Inc. said an analysis of the early-stage data of the company’s experimental Covid-19 vaccine showed mRNA-1273 induced immune responses in older adults that were similar to younger participants.

August 26, 2020/by Andrew Humphreys